Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Pfeffer Insider Profile
4 Followers
Matthew Pfeffer, Corporate VP and CFO at MannKind, holds 118.30K shares in Vivani Medical (Ticker: VANI), holds 373.00K shares in MannKind (Ticker: MNKD), holds 10.00K shares in DS Healthcare Group (Ticker: DSKX).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-12.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Pfeffer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Pfeffer
Matthew Pfeffer's Trading History
MannKind
Aug 29, 2017
Corporate VP and CFO
Uninformative Sell
469.65
$1.55M
Vivani Medical
Jun 05, 2018
Director
Uninformative Buy
―
$212.94K
DS Healthcare Group
Mar 31, 2014
―
Uninformative Buy
―
$20.00
List of latest transactions for each holding click on a transaction to see Matthew Pfeffer's performance on stock
You May Also Like
Matthew Pfeffer insider profile FAQ
What is the percentage of profitable transactions made by Matthew Pfeffer?
The percentage of profitable transactions made by Matthew Pfeffer is 50%.
What is the average return per transaction made by Matthew Pfeffer?
The average return per transaction made by Matthew Pfeffer is -12.60%.
What stocks does Matthew Pfeffer hold?
Matthew Pfeffer holds: MNKD, VANI, DSKX stocks.
What was Matthew Pfeffer’s latest transaction?
Matthew Pfeffer latest transaction was an Uninformative Buy of ―.
What was Matthew Pfeffer's most profitable transaction?
Matthew Pfeffer’s most profitable transaction was an Informative Sell of MNKD stock on July 2, 2014. The return on the trade was 46.10%.
What is Matthew Pfeffer's role in MannKind?
Matthew Pfeffer's role in MannKind is Corporate VP and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.